These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16869788)

  • 1. Exploiting the p53 pathway for the diagnosis and therapy of human cancer.
    Lane DP
    Cold Spring Harb Symp Quant Biol; 2005; 70():489-97. PubMed ID: 16869788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumour suppressor gene.
    Steele RJ; Thompson AM; Hall PA; Lane DP
    Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of the p53 pathway, apoptosis and cancer therapy.
    Vazquez A; Bond EE; Levine AJ; Bond GL
    Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What have animal models taught us about the p53 pathway?
    Lozano G; Zambetti GP
    J Pathol; 2005 Jan; 205(2):206-20. PubMed ID: 15643668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53 pathway.
    Prives C; Hall PA
    J Pathol; 1999 Jan; 187(1):112-26. PubMed ID: 10341712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.
    Huang CL; Yokomise H; Miyatake A
    Future Oncol; 2007 Feb; 3(1):83-93. PubMed ID: 17280505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the p53 pathway.
    Pietsch EC; Humbey O; Murphy ME
    Oncogene; 2006 Mar; 25(11):1602-11. PubMed ID: 16550160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Antibodies in the sera of patients with various types of cancer: a review.
    Soussi T
    Cancer Res; 2000 Apr; 60(7):1777-88. PubMed ID: 10766157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
    Soussi T; Hjortsberg L
    Trends Mol Med; 2009 Jan; 15(1):1-4. PubMed ID: 19097939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53--a natural cancer killer: structural insights and therapeutic concepts.
    Römer L; Klein C; Dehner A; Kessler H; Buchner J
    Angew Chem Int Ed Engl; 2006 Oct; 45(39):6440-60. PubMed ID: 16983711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy.
    Evan GI; Christophorou M; Lawlor EA; Ringshausen I; Prescott J; Dansen T; Finch A; Martins C; Murphy D
    Cold Spring Harb Symp Quant Biol; 2005; 70():263-73. PubMed ID: 16869762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 alterations in human cancer: more questions than answers.
    Soussi T
    Oncogene; 2007 Apr; 26(15):2145-56. PubMed ID: 17401423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of p53 mutations in human cancers.
    Pellegata NS; Ranzani GN
    Eur J Histochem; 1996; 40(4):273-82. PubMed ID: 9116334
    [No Abstract]   [Full Text] [Related]  

  • 17. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL; Russell PJ; Knittel T; Milross C
    Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting p53 for enhanced radio- and chemo-sensitivity.
    Lu C; El-Deiry WS
    Apoptosis; 2009 Apr; 14(4):597-606. PubMed ID: 19259822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic and novel roles of p53: prospects for anticancer therapy.
    Fuster JJ; Sanz-González SM; Moll UM; Andrés V
    Trends Mol Med; 2007 May; 13(5):192-9. PubMed ID: 17383232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.